Fri, January 19, 2024

Ross Osborn Reiterated (AXGN) at Buy and Held Target at $12 on, Jan 19th, 2024

Ross Osborn of Cantor Fitzgerald, Reiterated "AxoGen, Inc." (AXGN) at Buy and Held Target at $12 on, Jan 19th, 2024.

Ross has made no other calls on AXGN in the last 4 months.



There are 2 other peers that have a rating on AXGN. Out of the 2 peers that are also analyzing AXGN, 0 agree with Ross's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Ross


  • Caitlin Cronin of "Canaccord Genuity" Reiterated at Strong Buy with Decreased Target to $11 on, Thursday, December 7th, 2023
  • Mike Kratky of "Leerink Partners" Initiated at Buy and Held Target at $9 on, Monday, October 16th, 2023